Picture of Respiratorius AB (publ) logo

RESP Respiratorius AB (publ) Income Statement

0.000.00%
se flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Annual income statement for Respiratorius AB (publ), fiscal year end - December 31st, SEK millions except per share, conversion factor applied.

2019
December 31st
2020
December 31st
2021
December 31st
2022
April 30th
2023
December 31st
Period Length:12 M12 M12 M4 M12 M
Source:ARSARSARSARSPRESS
Standards:
SAS
SAS
SAS
SAS
Status:FinalFinalFinalFinalFinal
Revenue
Total Revenue0000.1330
Cost of Revenue
Gross Profit0.8950.8721.550.751.26
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Other Operating Expenses
Total Operating Expenses5.057.079.554.367.83
Operating Profit-5.05-7.07-9.55-4.23-7.83
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes-5.05-7.47-9.64-4.23-7.83
Provision for Income Taxes
Net Income After Taxes-5.05-7.47-9.64-4.23-7.83
Net Income Before Extraordinary Items
Net Income-5.05-7.47-9.64-4.23-7.83
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income-5.05-7.47-9.64-4.23-7.83
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS-0.03-0.038-0.043-0.014-0.027
Dividends per Share